معرفی
Holger Koch is Division Head of Human-Biomonitoring at the Institute for Prevention and Occupational Medicine–Institute of the German Social Accident Insurance (IPA), affiliated with Ruhr University Bochum, Germany. He is also an Honorary Professor at The University of Queensland, Australia, and Chair of the Human Biomonitoring Commission of the German Environment Agency (Umweltbundesamt), Berlin (HBM-Com).
His educational background includes a degree in Food Chemistry from the University of Würzburg and a Dr. rer. nat. in Occupational Toxicology and Food Chemistry from Friedrich-Alexander-University of Erlangen.
Dr. Koch's research centers on human biomonitoring, exposure assessment, and the analysis of endocrine-disrupting chemicals (EDCs) such as phthalates in blood and urine. His work emphasizes developing sensitive methods to assess chemical exposure in occupational and environmental contexts. Key areas include phthalates, human metabolism, and PBPK modelling to understand chemical kinetics in the body.
The recent publications highlight a strong trend in population-level biomonitoring, chemical prioritization, and methodological standardization in human biomonitoring studies. His research spans vulnerable groups like infants, children, and pregnant women, and addresses both industrial chemicals and pesticides across international contexts (Denmark, Ireland, EU).
He plays a significant leadership role as Chair of the HBM-Com, influencing national environmental health policy. While no formal students are listed, his extensive co-authorship with researchers like Alison Connolly, Ana Virgolino, and Marike Kolossa-Gehring indicates active collaboration and likely mentorship. He has contributed to major guidance frameworks, suggesting involvement in large-scale research initiatives and possibly grant-funded projects.
Dr. Koch is affiliated with key research entities including the IPA, Ruhr University Bochum, and The University of Queensland. His work is central to the HBM4EU initiative and similar international efforts to harmonize human biomonitoring practices.
